scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1016/J.LUNGCAN.2004.08.016 |
P698 | PubMed publication ID | 15713522 |
P2093 | author name string | David Johnson | |
Frances A Shepherd | |||
Lesley Seymour | |||
Barbara Graham | |||
James Rigas | |||
Keyue Ding | |||
Robert Livingston | |||
Timothy Winton | |||
Marlo Whitehead | |||
Naveed Alam | |||
P433 | issue | 3 | |
P921 | main subject | Canada | Q16 |
chemotherapy | Q974135 | ||
P304 | page(s) | 385-394 | |
P577 | publication date | 2005-03-01 | |
P1433 | published in | Lung Cancer | Q641464 |
P1476 | title | Compliance with post-operative adjuvant chemotherapy in non-small cell lung cancer. An analysis of National Cancer Institute of Canada and intergroup trial JBR.10 and a review of the literature | |
P478 | volume | 47 |
Q36752521 | A retrospective study: platinum-based induction chemotherapy combined with gemcitabine or paclitaxel for stage IIB-IIIA central non-small-cell lung cancer |
Q37228519 | Adjuvant chemotherapy after complete resection of non-small cell lung cancer |
Q35771994 | Adjuvant chemotherapy for resected non-small-cell lung cancer: future perspectives for clinical research |
Q35200745 | Adjuvant chemotherapy in patients with completely resected non-small cell lung cancer |
Q35200660 | Adjuvant chemotherapy of completely resected early stage non-small cell lung cancer (NSCLC). |
Q34126484 | Adjuvant chemotherapy of non-small cell lung cancer |
Q80420032 | Chemotherapy and surgery for operable NSCLC |
Q43948093 | Chemotherapy compliance in patients with osteosarcoma |
Q33924664 | Clinical symptoms and chemotherapy completion in elderly patients with newly diagnosed acute leukemia: a retrospective comparison study with a younger cohort |
Q41208260 | Compliance With Neoadjuvant Chemotherapy in T4 Oral Cancers: Place, Person, Socioeconomic Status, or Assistance |
Q85303113 | ERCC1 and the efficacy of cisplatin in patients with resected non-small cell lung cancer |
Q33594314 | Effects of Chinese Medicine as Adjunct Medication for Adjuvant Chemotherapy Treatments of Non-Small Cell Lung Cancer Patients |
Q63532892 | Effects of presurgical exercise training on cardiorespiratory fitness among patients undergoing thoracic surgery for malignant lung lesions |
Q35044346 | Fluorodeoxyglucose positron emission tomography and chemotherapy-related tumor marker expression in non-small cell lung cancer |
Q36467456 | Genetic and Prognostic Differences of Non-small Cell Lung Cancer between Elderly Patients and Younger Counterparts. |
Q24194081 | Immunotherapy for stage I-III non-small cell lung cancer treated with surgery or radiotherapy with curative intent |
Q43197895 | Improved compliance with adjuvant vinorelbine and cisplatin in non-small cell lung cancer |
Q37240128 | Non-small cell lung cancer in the elderly: defining treatment options |
Q52928581 | Operative outcomes of thoracoscopic lobectomy for non-small-cell lung cancer. |
Q35003631 | Pemetrexed for the treatment of non-small-cell lung cancer |
Q33429178 | Pemetrexed plus carboplatin as adjuvant chemotherapy in patients with curative resected non-squamous non-small cell lung cancer |
Q37346454 | Phase II study of docetaxel and vinorelbine as adjuvant chemotherapy for resected non-small cell lung cancers |
Q50109053 | Phase II study of nedaplatin and irinotecan as adjuvant chemotherapy for completely resected non-small cell lung cancer |
Q37089137 | Pneumonectomy after chemoradiation: the Dana-Farber Cancer Institute/Brigham and Women's Hospital experience |
Q48846109 | Predictors of non-compliance in autologous hematopoietic SCT patients undergoing out-patient transplants |
Q37347493 | Quality-adjusted time without symptoms or toxicity analysis of adjuvant chemotherapy in non-small-cell lung cancer: an analysis of the National Cancer Institute of Canada Clinical Trials Group JBR.10 trial |
Q37119462 | Quality-of-life outcomes for adjuvant chemotherapy in early-stage non-small-cell lung cancer: results from a randomized trial, JBR.10. |
Q99582717 | Radiomics nomogram for prediction disease-free survival and adjuvant chemotherapy benefits in patients with resected stage I lung adenocarcinoma |
Q33404434 | Randomized phase 2 trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed versus cisplatin and vinorelbine: the TREAT study |
Q39732809 | Resected pN1 non-small cell lung cancer: recurrence patterns and nodal risk factors may suggest selection criteria for post-operative radiotherapy. |
Q34564943 | Should patients undergoing chemotherapy and radiotherapy be prescribed antioxidants? |
Q43604929 | Stereotactic hypofractionated radiotherapy in stage I (T1-2 N0 M0) non-small-cell lung cancer (NSCLC). |
Q30417605 | The Peter Brojde lung cancer centre: a model of integrative practice |
Q38833767 | Therapeutic options following pneumonectomy in non-small cell lung cancer |
Q30249083 | Timely initiation of chemotherapy: a systematic literature review of six priority cancers - results and recommendations for clinical practice. |
Q28209997 | Trial on refinement of early stage non-small cell lung cancer. Adjuvant chemotherapy with pemetrexed and cisplatin versus vinorelbine and cisplatin: the TREAT protocol |
Q36977683 | UFT (tegafur and uracil) as postoperative adjuvant chemotherapy for solid tumors (carcinoma of the lung, stomach, colon/rectum, and breast): clinical evidence, mechanism of action, and future direction |
Q35674874 | Video-assisted thoracoscopic surgery is more favorable than thoracotomy for administration of adjuvant chemotherapy after lobectomy for non-small cell lung cancer |
Q83298998 | [Interdisciplinary treatment of non-small cell lung cancer] |
Search more.